Zdrowie i gospodarka · 25/04/2016
FDA Releases Revised Draft Guidance for Industry on Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products
The FDA has made available a revised draft guidance for industry on assay development and validation for immunogenicity testing of therapeutic protein products, providing recommendations for industry to develop and validate immune assays for assessing immunogenicity during clinical trials.